key: cord-1036502-33lrkne2
authors: Islam, Md Mamunul; Koirla, Dipak
title: Toward a next-generation diagnostic tool for pandemics: A review on emerging isothermal nucleic acid amplification techniques for the detection of SARS-CoV-2 and other infectious viruses
date: 2021-12-01
journal: Anal Chim Acta
DOI: 10.1016/j.aca.2021.339338
sha: 4da7bb49a4256fb58240838a67a363962cdcae77
doc_id: 1036502
cord_uid: 33lrkne2

As the COVID-19 pandemic continues to affect human health across the globe rapid, simple, point-of-care (POC) diagnosis of infectious viruses such as SARS-CoV-2 remains challenging. Polymerase chain reaction (PCR)-based diagnosis has risen to meet these demands and despite its high-throughput and accuracy, it has failed to gain traction in the rapid, low-cost, point-of-test settings. In contrast, different emerging isothermal amplification-based detection methods show promise in the rapid point-of-test market. In this comprehensive study of the literature, we critically review several promising isothermal amplification methods for the detection of SARS-CoV-2 that can also be applied to other infectious viruses detection. Starting with a brief discussion on the SARS-CoV-2 structure, its genomic features, and the epidemiology of the current pandemic, this review focuses on different emerging isothermal methods and their advancement. The potential of isothermal amplification combined with the revolutionary CRISPR/Cas system for a more powerful detection tool is also critically reviewed. Additionally, the commercial success of several isothermal methods in the pandemic and different variants of SARS-CoV-2 and their implication on disease diagnosis are discussed. We address the three most crucial aspects in achieving a simple, fast, and multiplexable platform.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has continued to spread in many countries since the first case was reported in Wuhan, China, at the end of 2019 1,2 , Subsequently, local human-to-human transmission of the virus occurred rapidly. Within months, it had spread across the globe 3, 4 . Within the next nine months, the pandemic caused have been able to control the pandemic to at least some extent, largely due to widespread testing and vaccination. However, the number of cases reported has fluctuated widely in highly populated countries, including India, Mexico, Bangladesh, Indonesia, Brazil, and Russia.

As of 20 November 2021, more than 5 million people have died due to the current pandemic and approximately 260 million cases of infection have been reported across a total of at least 223 countries and territories 5 . Figure 1 illustrates a timeline of some of the major events of the pandemic. This numbers are increasing as the virus is evolving with different infectious variants emerging in different countries. Vaccines can provide an avenue for mitigating the spread of the pandemic, however, breakthrough infections can still happen due to the lessened vaccine effectiveness over time 6, 7 . Thus, a system for rapid, simple, and high throughput diagnostic testing for the detection of SARS-CoV-2 has a crucial role to control the pandemic. Different aspects of SARS-CoV-2, such as the structural properties, genomic information, mode of transmission, mechanism of binding to host cells and replication, have been well studied [8] [9] [10] [11] [12] . The virion is mostly spherical, with a diameter in the low nanometer range (~100 nm) 13, 14 . A transmission electron microscope image (Figure 2A) shows spherical SARS-CoV-2 particles that were obtained from an isolate of the first case in the USA provided by the CDC 15, 16 . The main feature of SARS-CoV-2 is four structural proteins (spike (S), membrane (M), envelope (E), and nucleocapsid (N)) ( Figure 2B ).

J o u r n a l P r e -p r o o f The virus genome is a positive-sense, single-stranded RNA 29,903 bases long 9 , which makes it one of the largest genomes of the well-known RNA viruses, such as influenza (13.5 kb) 17 , rhinovirus (7.2 kb) 18 , Zika (10.8 kb) 19 , HIV (9 kb) 20 , and Ebola (~19 kb) 21 ( Figure 2C ). This relatively long genome of SARS-CoV-2 carries necessary genetic information to encode diverse structural and nonstructural proteins ( Figure 2D) . The upstream region, near the 5'

end of the genome, contains two large open reading frames (~21 kb), that encode a polyprotein that is cleaved by proteases (protease originated from the polyprotein) into nonstructural proteins of the virus, including an RNA-dependent RNA polymerase (RdRP) and an exonuclease 13 . Near the 3' end, the genome encodes four structural proteins 22 : S, E, M, and N proteins. These proteins define the structure of the virus particle and thereby its ability to infect the human body. There are also interspaced regions between the four structural proteins for accessory proteins in the same 3' end of the genome. The S protein of the J o u r n a l P r e -p r o o f coronavirus is the key to mediating the host-pathogen interaction. The virus infects people preferentially through the S protein by the combined action of its two functional subunits.

One of the subunits, S1, binds between the virus particle and the host cell receptor angiotensin-converting enzyme 2 (ACE2) (Figure 2B) . The other subunit, S2, facilitates the fusion of the host cell membrane and the virus particle 23 . The overall role of the S protein in the efficient entry and infectivity of the virus has been reported elsewhere 24, 25 . surfaces provide the greatest stability over a wide range of temperature (4-37 °C) 28 .

SARS-CoV-2-infected people develop common respiratory illness symptoms including fever, shortness of breath, loss of smell and taste, headache, and fatigue ( Figure 3B ). Older infected people (>60 years) are more likely to experience greater disease severity 29 . In particular, older people with pre-existing disease are prone to severe illness manifested by acute respiratory distress syndrome, which most often leads to death. However, many of the infected people show very mild or no clinical symptoms 30 Copyright 2021. Created with BioRender.com.

Ideally, a routine testing practice prior to the development of symptoms and isolation of the suspected individual is the crucial way to control virus transmission. However, the lack of adequate testing in many countries limits their ability to correctly assess the extent of the pandemic, which catalyzes the fast spread of the virus in many parts of the world. In many resource-limited countries, tests are preferentially performed on people who have clinical symptoms or have been exposed to SARS-CoV-2, leading to difficulty assessing the true spread of the disease. After more than a year, promising vaccines have been developed and are now being administered 32 . However, routine testing for SARS-CoV-2 will still be necessary as we enter the post pandemic era for monitoring long-term vaccine efficacy.

Nucleic acid-based testing and rapid antigen tests are the two classes of viral testing methods widely employed as diagnostic tests. As the name suggests, rapid antigen tests detect the presence of viral proteins in respiratory specimens typically by a lateral flow immunoassay approach. Most of these type of detections only take minutes to complete, are inexpensive, and can be used in POC settings 33 . However, they are inherently less sensitive J o u r n a l P r e -p r o o f than nucleic acid-based test. Unlike rapid antigen tests, nucleic acid-based test involves target amplification, making it a highly sensitive detection method ( Figure 3C ).

Antibody tests are also used in some cases. Antibody-based tests commonly detect anti-SARS-CoV-2 IgM and IgG antibodies in blood using lateral flow assays or enzyme-linked immunosorbent assay (ELISA) 34 . A detailed discussion of this type of test can be found elsewhere [35] [36] [37] . Viral infection triggers the generation of antibodies. For serological tests, a detectable level of the IgM antibody is generated after at least one week of infection and gradually deceases after three weeks of infection, while the IgG antibody is generated after two weeks of infection and may remain detectable for weeks ( Figure 3D ).

Because antibody-based tests detect host immune response as opposed to viral components of SARS-CoV-2 and the less sensitive nature of rapid antigen tests; nucleic acidbased molecular test is considered the standard method of SARS-CoV-2 detection. Nucleic acid-based test sensitively detects genetic footprints in one or more specific target regions of the SARS-CoV-2 RNA. The ability of molecular test to sensitively detect viral RNA depends on several factors, such as the durations of the incubation period, viral shedding, and onset of symptoms, each of which has a time window with relative intensity 38, 39 (Figure 3D ). Infection occurs with exposure to the virus and a subsequent incubation period of a few days 40 before clinical symptoms begin to surface in the body 41 . Viral shedding starts a few days before the onset of symptoms, and the viral load reaches its maximum level within the first week of symptoms onset; therefore, infectiousness corresponds to the same time window. In addition, the clinical sensitivity of molecular tests often depends on the time relative to the symptoms onset and on the viral load in an individual 42, 43 . Typically, viral loads start to reach at peak just before symptoms and persist a little more than a week, although can be at peak for prolonged time 44 Moreover, RT-PCR requires specific workplace standards to establish a high-efficiency assay.

In particular, viral RNA detection via RT-PCR is very sensitive to contaminants present from J o u r n a l P r e -p r o o f 9 raw clinical samples during RNA extraction 52 . Inhibitors affect DNA polymerase activity in the amplification steps and can significantly reduce the amplification efficiency.

One distinctive advantage of an isothermal-based amplification method is that it amplifies the target nucleic acid at a constant temperature, thus avoiding the requirement for an expensive thermal cycler. Ideally, any isothermal amplification can be performed with a very simple heating source such as a water bath or Peltier heater requiring minimal energy input. This feature of isothermal amplifications enables them to function as POC-based tests.

Moreover, different amplification mechanisms of several emerging isothermal methods allow detection assays to be run at a wide range of temperatures. The fluorescence probes used in RT-PCR can be expensive, while colorimetric indicators used in isothermal amplification are readily available at low cost.

Promising isothermal amplification methods started to emerge in the early 1990s, i.e., within a few years after the invention of PCR 53 their implications on the isothermal-based detection are also discussed.

Loop-mediated amplification (LAMP) was first reported in 2000 by Notomi et al., 61 .

LAMP is typically performed between 60 and 65 °C. Similar to RT-PCR, RT-LAMP also detects RNA-based viruses with a reverse transcription process prior to amplification in single tube assembly. However, unlike RT-PCR, both RT and LAMP reactions of RT-LAMP can be carried out at ~65 °C. LAMP requires higher number of primers than PCR. Two pairs of primers, generally known as inner primers (forward and backward) and outer primers (forward and backward), are required. The two inner primers recognize four of six specific regions of the target nucleic acid, and the two outer primers recognize the other two regions. However, most current LAMP-based studies use two additional primers (loop primers) in order to accelerate amplification by annealing to the loop region in the stem-loop structure 62, 63 . Figure   4 shows a simple representation of LAMP mechanism.

J o u r n a l P r e -p r o o f 

The LAMP product can be detected by various real-time and endpoint readout modes.

Among them, turbidity is one of the oldest readout modes, and it is based on the creation of Fluorescence-based detection is also a widely used readout mode of LAMP.

Intercalating dyes have been used to detect LAMP products. One of the advantages of using fluorescent dyes is that they enable both qualitative and quantitative real-time detection. In real-time fluorescence-based assays, the amplified LAMP product is characterized by the threshold time, Tt 83 , which is similar to the cycle threshold Ct in PCR. The selection of dyes is crucial for fluorescence-based LAMP readouts. SYBR Green I has been commonly used 84, 85 as an intercalating dye that emits green fluorescent light upon irradiation with UV light when bound to dsDNA; PicoGreen and ethidium bromide dyes are also used for the same purpose [86] [87] [88] [89] . However, some of these dyes inhibit the LAMP reaction. A detailed comparison of a large number of dyes and their inhibitory effects on the LAMP reaction shows that SYBR Green I significantly inhibits the amplification reaction, while most of the SYTO dyes show no or very little inhibition based on three metrics: the LOD, the signal-to-noise ratio and the Tt 90 . A similar study suggests that SYBR Green dyes are more inhibitory than SYTO dyes 91 . Although widely used in nucleic acid-based amplification reactions, SYBR Green I also inhibits PCR 92, 93 .

LAMP products can also be detected electrochemically. Different redox-active substances, such as methylene blue 94, 95 and ruthenium hexamine 96, 97 , are employed for quantitative and qualitative detection. Other notable detection modes include gold nanoparticle (AuNP)-based detection 98 , antibody-based lateral flow assay 99 , and traditional J o u r n a l P r e -p r o o f postamplification analysis by gel electrophoresis. For a comprehensive review of different LAMP readout modes, the interested readers are directed to a study by Zhang et al., 100 .

The mode of detection of LAMP or any other isothermal amplifications, endpoint or real time, is selected and implemented mainly based on the specific requirement of the assay and available resources. In principle, endpoint modes do not require expensive, sophisticated instrumentation; however, this benefit is offset by them providing only qualitative or lessquantitative information. On the other hand, real-time modes report amplification progress and provide quantitative information, thus generally requiring high-cost, complex instrumentation. 119 , making it a less common target 120 . Compared to other structural genes, the N gene is highly conserved 121, 122 , thus less likely to be mutated. This gene is one of the best molecular targets for in vitro diagnostics 119 Another interesting assay was based on two distinct primer sets that selectively targeted both the ORF1ab and N genes 135 ; it employed a nanoparticle-based colorimetric readout system for the simultaneous detection of both genes. Fluorescein (FITC)-and digoxigenin-modified primers were used to amplify the ORF1ab and N genes, respectively.

The authors described the multiplexity of the test by amplifying both the target genes in a single reaction platform. They tested pre-confirmed samples of both positive and negative cases. The assay detected all 33 positive clinical samples when targeting both genes in parallel. When targeting only one gene, they found approximately 15% false-negative results, which showed that targeting more than one region in an RT-LAMP assay can provide better performance.

Using a single, constant operating temperature in the near 65 °C certainly has distinctive advantages over PCR-based viral detection. However, undesired cross-reactivity in LAMP reaction can be an issue because of a higher number of primers. With the emergence of different variants of SARS-CoV-2, the existing LAMP assay should be reconfigured with adding more variant specific primers. Adding one or more common mutations among the widely circulated infectious variants as additional target regions, LAMP`s clinical sensitivity should be reevaluated. Designing and optimizing primers against multiple target regions of the viral RNA can increases the complexity. The primer sets against all the targets might be fully specific but not equally sensitive in LAMP reactions; thus, the interpretation of clinical tests from a multitarget LAMP test might be challenging.

The nicking endonuclease amplification reaction (NEAR), also reported as nicking enzyme-assisted amplification (NEAA) or nicking enzyme-mediated amplification (NEMA), is an enzymatic isothermal amplification reaction 136 . Commercially, Abbott Diagnostics has been developing NEAR-based influenza virus as well as SARS-CoV-2 detection systems 137 .

The key components of NEAR are a pair of target-specific primers, forward and reverse, each designed with three distinctive sites, and two highly efficient enzymes: strand-displacing DNA polymerase and nicking endonuclease. There are a wide range of commercially available J o u r n a l P r e -p r o o f nicking endonuclease enzymes active over a wide range of temperatures, each with a unique nicking sequence that they recognize 138, 139 . Figure 6 illustrates NEAR with two primers, P1 and P2, each containing a stabilizing region at the 5' end, a target binding region at the 3' end and a nick recognition site in the middle. to the target and is also extended by highly processive and promiscuous DNA polymerase while efficiently releasing the prior extended strand. The primer P2 readily binds to this released strand. As extension occurs by the polymerase, a nicking recognition site is generated on the duplex. The nicking endonuclease readily recognizes the site and creates a nick, while the polymerase enzyme displaces the nicked strand to start another extension process. Therefore, from the primer-target interaction at the beginning and the subsequent combined action of the two enzymes, a NEAR duplex is generated. This duplex acts as the J o u r n a l P r e -p r o o f seed for the subsequent exponential amplification. The duplex undergoes nicking at both ends. Polymerization of the resulting templates generates shorter duplexes, which further undergo nicking to generate single-stranded products. The primers hybridize with these products, and the processes repeat to generate shorter duplexes in a positive feedback loop, resulting in exponential amplification.

However, the downside of this reaction is frequent nonspecific product formation, which limits the sensitivity of NEAR. Nonspecific product formation can be suppressed by carefully designing the primers, selecting appropriate enzymes, and optimizing the reaction conditions. Key experimental parameters, such as the experimental temperature, the relative concentrations of both polymerase and nicking endonuclease, the Mg 2+ concentration enabling the activity of both enzymes, dNTPs, and multiple sets of primer candidates and their concentration, need to be optimized.

The Nucleic acid sequence-based amplification (NASBA) was first reported in 1991, making it one of the oldest isothermal amplification methods 141 . NASBA has been used to detect different RNA-based infectious viruses, such as hepatitis A virus (HAV) 142 , human immunodeficiency virus type 1 (HIV-1) 143 , and hepatitis C virus (HCV) 144 . To amplify target RNA 145 , NASBA method require three enzymes (reverse transcriptase, RNase H, and T7 RNA polymerase) and two target specific primers. One of the primers are designed to contain the T7 polymerase promoter sequence. Figure 7 illustrates the amplification principle of NASBA.

Detection of viral RNA via NASBA usually starts with a brief initial denaturation step at 65 °C to disrupt secondary RNA structure prior to isothermal amplification at 41 °C. The reaction starts with hybridization of the target RNA to the primer that contains the T7 polymerase promoter sequence ( Figure 7A) . Figure 7B . However, in this study, patient samples were not used for clinical validation.

NASBA-based commercial diagnostic system is available. The fully automated NASBAbased diagnostic system NucliSENS EasyQ was developed by BioMerieux 154 and has been widely employed for virus detection 155, 156 . The NASBA-based assay generates RNA products; therefore, it is crucial to maintain RNase-free conditions to ensure RNA stability. Another concern is that when amplification occurs at mild temperature, low-stringency reaction conditions may cause nonspecific amplification. Using an ice bath to assemble enzymatic reaction mixture or keeping enzymes separate and adding them to the remaining amplification mixture immediately before amplification can avoid nonspecific amplification.

The principles of transcription-mediated amplification (TMA) and NASBA are very similar, and they have similar readout modes. Similar to NASBA, TMA also involves synthesis of cDNA from target RNA and reverse transcriptase interaction, formation of dsDNA and generation of IVT RNA amplicons by T7 RNA polymerase. However, TMA uses two enzymes, reverse transcriptase and RNA polymerase 145 . The unique reverse transcriptase enzyme also possesses RNase H activity; thus, TMA functions without an additional RNase H enzyme 157 . A TMA-based isothermal system detected the presence of RNA viruses in clinical samples 158 and was more sensitive than RT-PCR in hepatitis C virus detection in liver tissue 159 . Similar to NASBA, TMA also needs optimized reaction conditions and careful primer design to limit nonspecific amplification.

A newer isothermal technique, recombinase polymerase amplification (RPA), was first reported in 2006 160 . RPA operates between 37 and 42 °C. Three key proteins, recombinase J o u r n a l P r e -p r o o f (UvsX), strand displacing polymerase (Bsu), and single-stranded binding (SSB) protein (gp32), and other accessory proteins are needed for RPA. RPA starts when the recombinase forms a nucleoprotein complex with two specific primers, i.e., forward and reverse primers designed based on a specific target. This binding of the recombinase protein to primers is assisted by the loading factor, UvsY. Creatine kinase is used to generate ATP and provides energy for the recombinase protein. Fascinatingly, a study reported that RPA can be performed even with no equipment by using only body heat 162 . In that study, RPA was performed to detect HIV-1 DNA by incubating the reaction mixture near different parts of the human body.

RPA has also been used to detect SARS-CoV-2 163 can be used to monitor RPA reaction. The two primers needed for RPA can be designed with the computation tool PrimedRPA 166 . The smaller number of primers in RPA might make it simpler than LAMP; however, RPA often suffers from lower specificity than LAMP 167 . Since

RPA is active at lower temperatures, using an ice bath to assemble the reaction mixture prior to amplification might restrict nonspecific amplification to a minimum.

There are some other promising isothermal methods that are well known in nucleic acid-based detection of infectious viruses, including but not limited to RAMP, RCA, CPA, HDA, and SMART. SARS-CoV-2 detection studies with these methods are rare; however, all these methods have great potential for use in viral and pathogenic detection, and it is worth discussing these methods briefly in this section.

RAMP is a two-stage isothermal amplification based on a combination of RPA and LAMP. RAMP reportedly showed at least tenfold higher sensitivity than either RPA or LAMP alone 168 increases complexity in assay design due to several different types of primers and enzymes involved in the two different isothermal methods.

Rolling circle amplification (RCA) is a widely researched isothermal method 170 (Figure 9) . In this proof of principle study, the target-initiated RCA generated the first set of amplicons, which acted as targets for the next round of RCA. The amplicon coils from this second round RCA conjugated with magnetic nanoparticles for optomagnetic detection. However, this report used synthetic complementary DNA of the target viral gene, not actual viral RNA from clinical specimens. After two rounds of RCA, the amplified product was detected with an optomagnetic sensing platform.

MNP-magnetic nano particles. Figure adapted with permission from Ref. 175 .

Recently, another RCA-based study reported SARS-CoV-2 detection using two target gene regions of N and S 176 . The RCA products were hybridized with detection probes modified with redox dyes to be detected electrochemically (differential pulse voltammetry). While promising, the study had some limitations for the method to be further applied as a diagnostic tool. Although no thermal cycling is required, multiple operating temperatures were reported for different steps throughout the process. It requires post amplification washing steps, which might be a deterrent for a POC application.

The signal-mediated amplification of RNA technology (SMART) is a simple isothermal amplification method 177 with the target at adjacent sites. The two probes also include a region that is much shorter and allows them to hybridize with one another. This specific design criterion allows the probes to form a 3WJ complex in the presence of the target of interest, which serves as the "seed"

of the subsequent amplification. Figure 10 illustrates the principle of SMART. The DNA polymerase, in the reaction mix, extends the shorter probe (or extension probe) using the template probe. that are active at the same temperature, it has the potential to detect infectious viruses.

Helicase-dependent amplification (HDA) is another promising isothermal amplification for nucleic acid analysis of pathogens 180, 181 Figure 11 illustrates a simple HDA principle. concern of HDA-based assays is undesired primer-dimer formation and off-target primer binding leading to misleading or nonspecific amplification 192 .

Cross-priming amplification (CPA) is another emerging isothermal amplification method for pathogen detection [193] [194] [195] . It relies on a higher number of primers and a smaller number of enzymes to amplify a target of interest. First developed and commercialized by Ustar Biotechnologies (Hangzhou, China) 196 , CPA requires one enzyme-DNA polymerase with strand-displacing activity, which might be advantageous for low-cost assays. However, several primers are required for CPA, three to five with at least one specially designed longer primer is known as a cross primer 194 The other ssDNA product from this step forms a hairpin-like structure followed by cross priming extension to create a dsDNA structure, which further generates two hairpin structures. High concentrations of primers and highly active Bst polymerase facilitate a series of annealing, extension, and displacement processes, leading to exponential amplification of dsDNA. The CPA product is dsDNA and thus can be read out by fluorescence mode. However, several recent studies used simple lateral flow strip-based detection, showing the diverse detection modes of CPA [197] [198] [199] . CPA is a relatively new isothermal approach and is being further developed 194 .

Often known as "genetic scissors," the CRISPR/Cas system is a revolutionary discovery in molecular biology 200 . It was discovered in bacteria as a naturally occurring phenomenon in their genome. Some bacteria survive viral attacks and develop resistance against any such future attack by copying part of the genetic sequence of the invading virus and storing it in the immune system 201, 202 . This defense mechanism of the bacteria is expressed as clustered regularly interspaced short palindromic repeats, termed CRISPR. It is the specific "spacer" sequence in the genome of bacteria located between palindromic sequence repeats that relate to viral genomes 203 . As an immune response against the attacking virus, this signature spacer sequence is transcribed into small RNA molecules 204, 205 . RNA, along with certain enzymes in bacteria, forms the CRISPR/Cas-based adaptive immune system 204, 206 , which protects bacteria by destroying the DNA or RNA of the invading virus 207 . Interestingly, it was later found that this natural immune system of many bacteria (also archaea) can be engineered for use as a genetic tool in mammalian cells 208 performs dsDNA cleavage using the endonuclease ability of the RuvC domain 254 . In addition to target cleavage, Cas12, unlike Cas9, also provides collateral cleavage activity (also referred to as trans-cleavage) on any ssDNA in the sample, a useful property in nucleic acid-based detection 255 . It enables a ssDNA reporter probe modified with fluorophore and quencher groups to be used to monitor an assay ( Figure 13C) .

Cas14, another type V effector protein, has been reported recently 225, 256 . Similar to Cas12, it can exhibit indiscriminate cleavage of ssDNA 239 . However, unlike Cas12, Cas14 does not require a PAM sequence in the target 225 , and it is much smaller in size, with ~400-700 amino acids 225 . The Cas14 family preferentially targets ssDNA ( Figure 13D) . The PAMindependent target cleavage of this newer class 2 enzyme has great potential to enable detection of a wide variety of ssDNA-based pathogens. Although ssDNA is preferentially targeted by Cas14, dsDNA can also be targeted by Cas14 by providing a TTTA PAM sequence 257 .

Cas13 family effector proteins, belonging to type VI, are unique in their target and collateral cleavage. Unlike the other class 2 Cas enzymes, Cas13 specifically targets and cleaves ssRNA 258 and does not require a PAM sequence in the target ( Figure 13E) . However, for the target recognition it prefers a non-guanine base or protospacer flanking site (PFS) to be present next to the protospacer, which can be easily found. With a similar size (~900-1300 amino acids) 251 to Cas12, the well-known subtype from the Cas13 family for pathogen J o u r n a l P r e -p r o o f detection is Cas13a 259 . Due to its ssRNA targets, Cas13 is especially suitable for RNA-based virus detection, including detecting SARS-CoV-2 260, 261 .

Isothermal amplifications such as LAMP and RPA are combined with different Cas enzymes involved with the CRISPR system for viral RNA (SARS-CoV-2) detection (Figure 14) .

Isothermal-based CRISPR/Cas detection systems can be performed with simple equipment, even a water bath 262, 263 . Ideally, CRISPR/Cas-based detection can be performed with fluorophore and quencher-modified nucleic acid reporters. This method generates a specific signal based on the cleavage of the reporter fluorescence probe, which allows simple visual detection 264 . Another simple way that is more amenable to POC detection is to interpret the result by employing a lateral flow assay, similar to a pregnancy test strip [265] [266] [267] [268] [269] The LOD was as low as 10 copies per µl of the reaction, suggesting high sensitivity of the assay, and the selectivity of the assay was confirmed using other coronaviruses. Clinical samples were preidentified with RT-PCR, and DETECTR could detect 100% of the negative samples correctly and 95% of the positive samples. The researchers attempted detection with a crude sample to avoid the RNA extraction step but found that this resulted in a significantly lower sensitivity. The Cas12 used in DETECTR is constrained by the PAM site in the target, which typically deters a CRISPR/Cas system from wide applicability. Another concern with DETECTR is its post amplification tube opening. It is ideal for nucleic acid-based detection in a single pot with a sample. CRISPR/Cas brings a high degree of specificity in isothermal amplification. CRISPR/Cas systems are designed considering target-specific gRNA, which directs them; thus, these systems act upon the amplified products from the target sequence, thus avoiding any carry over primer-dimer products. However, we must acknowledge the limitations and challenges of this promising detection system. CRISPR/Cas-based system coupled with isothermal amplification is essentially an enzyme-intensive process, which might be expensive. To incorporate the CRISPR/Cas system with isothermal amplification for pathogen detection, the choice of Cas enzymes must consider the operating temperature of the isothermal amplification. Choice of Cas enzymes also depends on the target nucleic acid. The amplified product from an isothermal amplification reaction is employed as the target of downstream Cas J o u r n a l P r e -p r o o f protospacer region needs to be selected so that the first base immediately after the protospacer region avoids a guanine base, which can be frequently satisfied by careful selection of the protospacer. Similar to Cas13, Cas14 also executes PAM-independent cleavage. However, Cas13 and Cas14 are currently not commercially available 289 ; thus, they are obtained by in-house protein expression and isolation in working labs.

Since the pandemic began, emerging isothermal-based detection systems have Isothermal techniques other than LAMP have also enjoyed commercial success and have obtained EUA in the pandemic. The Hologic Panther system uses a TMA-based SARS-CoV-2 assay 297 , and it is a large-scale clinical testing system capable of running over 1000 tests in a day. This fully automated platform has been used to sensitively detect different human coronaviruses (hCoVs) 298 , and one study even found that its analytical performance was higher than that of RT-PCR 299 .

J o u r n a l P r e -p r o o f NEAR-based isothermal amplification was employed by Abbott for a diagnostic system for the influenza virus 300 . Formerly known as "Alere i", the isothermal system has been available on the market for a few years for detecting the flu virus 301, 302 . An improved version, "Abbott ID Now", was developed for SARS-CoV-2 detection and also received EUA from the FDA 303 . From direct swab, the "ID NOW COVID-19" testing platform can detect viral RNA in less than 15 min. ID NOW COVID-19 is an integrated diagnostic platform of a sample processing unit and detection system with a small device footprint for POC facilities ( Figure   15A ). Test Kit"-a commercial POC testing system developed by Lucira Health. The system involves a userfriendly, simple workflow of "self-test" virus detection on a small and portable device. (adapted with permission) 304 .

Lucira Health, a California-based company, developed an impressive isothermal-based detection system 304 . The kit is a small portable device powered by two AA batteries. This CLIAwaived kit enables at-home testing with very simple and nontechnical steps ( Figure 15B) For these commercial kits and other diagnostics systems, EUA is issued for a certain time in unusual situations such as a pandemic that demands widespread testing. Therefore, large-scale comparative studies of these kits using various sample types collected from symptomatic and asymptomatic patients are necessary before permanent approval and thus regular testing in the post-pandemic era.

For detecting SARS-CoV-2, along with these commercially successful isothermal amplification systems, the analytical performances of some isothermal-based studies in the literature are summarized in Table 2 .

J o u r n a l P r e -p r o o f 

Isothermal amplification-based assays can be improved to become better alternatives to PCR as a detection system for highly infectious viruses. The main argument in favor of isothermal detection methods is that unlike PCR-based detection, they are not based on repeated temperature switching. While this is true for the amplification part, when we consider the entire assay from sample treatment to detection, it often requires more than one temperature, which is not convenient for an ideal sample-to-answer approach. In some assays in the literature, analytical performance is compared to that of PCR by using mock samples with viral RNA spiked into a biological fluid 128, 146, 164 . Those analytical sensitivity tests with simulated samples may not yield the same results or even can give false negatives using clinical specimens. Clinical studies using different types of specimens are required to know the robustness and true sensitivity of the assay. It is particularly important as potential falsenegative results can have a significant effect on disease containment. Getting accurate results from even a well-designed and sensitive isothermal assay is not always guaranteed. For example, an optimized and "highly specific" assay can generate false-positive results in different settings because of human error such as improper sample handling, reagent mixing, or even mislabeling. A simple and reduced workflow, sample-to-answer assay can prevent these potential sources of false positives and ensure diagnostic specificity.

An infectious virus such as SARS-CoV-2 demands moving the testing environment from the benchtop to the field, from the clinical laboratory to POC settings-making a nextgeneration diagnostic tool available for routine testing rather than being limited by cost, time, or laboratory facilities. Such a tool would be inexpensive, readily available to end users, operable with minimal technical knowledge, portable with a minimal instrument footprint, and able to detect quickly with fewer reagents and at a single temperature. Isothermal methods are faster and simpler than non isothermal PCR-based methods, and the amplified product can be detected visually with an unaided eye, making them good candidates for nextgeneration diagnostic tools. As the scientific community and commercial developer continue to make progress on this front, three questions must be asked: How easy is it to process easy sample treatment, POC tool, and multiplexable system.

Detection of SARS-CoV-2 requires extraction of its RNA from clinical samples, which involves several time-consuming steps 309 , is labor-demanding, and is often impossible to perform with shortages of extraction kits. An isolation-free RNA method would significantly reduce the turnaround time and cost of the test. Some reports have shown that RT-PCR can be performed using patient samples directly [310] [311] [312] [313] . Using raw clinical samples should be more convenient with LAMP than PCR, as LAMP is more tolerant to inhibitors 314 146, 315 . However, using saliva with a pH-dependent colorimetric LAMP method might generate misleading results, as human saliva reportedly changes the pH from 7.4 to 6.8 320 .

Even these small changes in pH can induce phenol red, a common colorimetric indicator of LAMP, to change from red to yellow, even without the presence of a viral RNA target that initiates LAMP. To overcome potential false positives from saliva samples, Yang et al.,

reported RT-LAMP 321 that used a "saliva stabilization solution" that contained 14.5 mM NaOH to reduce the salivary acidity. The study reported that the saliva-based LAMP assay provided faster detection with fewer false positives than a RT-PCR test with EUA.

Along with minimal sample processing, the next important criterion for a nextgeneration diagnostic tool is that it would be scalable and user-friendly to allow routine The POC platform integrated the necessary heating elements, LEDs, dye-specific spectrum filters, and a smartphone to capture fluorescence images with real-time monitoring ( Figure   17B ). A small microfluidic device made of polyurethane was used as the reaction chamber.

The channel network for fluidic transmission in the device was designed to contain three distinctive regions: inlet, mixing and amplification regions ( Figure 17C ). The two fluids enter the mixing zone before heading into a circular amplification region, where the reaction occurs.

The microfluidic chip is then inserted into the platform where an integrated heater provides the operating temperature (65 °C). This system detects a positive sample in 30 

Performing multiple genotyping tests on one virus or testing for several viruses in a single reaction is used in a multiplexable detection approach. Multiplexing is highly desired in bioanalysis and more so for pathogen detection since many viruses have similar genetic material and their infections have similar clinical symptoms; therefore, accurately detecting as many of these related pathogens as possible in a single reaction is desired. Respiratory pathogens such as SARS-CoV-2 have similar genetic material to other members of its Coronaviridae family. Early in the pandemic, a report was published by a group of researchers in China 326 who conducted a study on a large number of people in a hospital in Wuhan, China.

They found that out of 307 patients, approximately 57% were infected by SARS-CoV-2 and at least one other influenza virus. Although non isothermal, PCR revolutionized the molecular biology field and biosensing applications because it is amenable to multiplexing, where more than one target can be amplified in a single reaction [327] [328] [329] [330] [331] . An RT-PCR-based multiplexed system was developed by US CDC named as "Flu SC2 Multiplex Assay" to codetect SARS-CoV-physical barriers among multiple isothermal reactions in microfluidic reaction platforms with multiple reaction chambers -the latter simplifies detection drastically by allowing the detection of only one target per reaction chamber.

In both cases, the greatest challenge is developing a convenient signal readout system for all intended targets (the probes and their chemistry, i.e., optical, electrochemical, and potentially label-free). Evaluating whether a single readout mode can be used for multiple targets or a combination of modes needs to be used 333 is central for multiplex assays. For simplicity, a convenient signal readout that can monitor multiple probes is preferred. In fluorescence readouts, multiple target-specific fluorescence probes with distinctive emission wavelengths can be used. Several double-modified probes labeled with multiple reporter dyes with unique spectral properties need to be designed carefully to specifically bind to their intended target sites. Such an approach was adapted in a promising LAMP-based multiplex method named detection of amplification by release of quenching (DARQ) 334 . In this method, in addition to other primers for a typical single target LAMP, a modified forward inner primer and a shorter reporter oligonucleotide are used. A 5' quencher-modified FIP primer is pre- Another probe-based multiplex LAMP is based on a molecular beacon probe. Each end of the probe contains a short complementary region to make a hairpin-like structure 337 . The target-specific molecular beacon is a dual-modified probe with a quencher on one end and a fluorophore on the other. In its native state, the probe is non-fluorescent because of the proximity of the fluorophore and quencher groups. The opening of the molecular beacon probe and the disruption of its hairpin structure activates the probe to report fluorescence signal. This conformational change only occurs upon binding with a target specific strand.

Using different molecular beacons with different fluorophores permits multiplex detection. A recent multiplex LAMP assay "Multiplex LAMP-BEAC" uses molecular beacon probes to detect multiple target genes of SARS-CoV-2 in saliva specimen 338 . High-throughput detection is also desired in a pandemic like COVID-19. In this context, pooled testing is adapted for initial screening purposes. A pooled testing approach can improve existing isothermal-based tests with reduced consumption of testing reagents. In this approach, laboratories can combine the same type of specimen collected from several persons to perform only one test on the combined pool of specimens 340 . A negative result essentially confirms each of the specimens as negative. However, a positive result from a J o u r n a l P r e -p r o o f pooled test may warrants each of the specimens to be tested separately to determine which person is infected 341 .

Viruses naturally mutate over time, as characterized by changes in the genetic sequence. After nearly two years since the first case reported in Wuhan China, SARS-CoV-2 has also mutated, giving rise to different variants 342 (residues 1-686) and S2 subunits (residues 687-1273) of the spike protein ( Figure 18) . Notably, the receptor-binding domain (RBD) in the S1 subunit contains several mutations, such as the K417N mutation in Beta and Delta, E484K mutation in Beta and Gamma, N501Y (common mutation in Alpha, Beta, and Gamma), and L452R and T478K mutation in Delta variant 344 .

These mutations in the RBD likely allow variants more effective in binding and infecting host cells and contribute toward high transmission and rapid spread in many countries 345, 346 . For example, the recent surge in Delta variant cases in different countries including the United States indicates its high transmissibility and reportedly it is 60% more transmissible than the Alpha variant 347 . It is suggested that the presence of furin cleavage site in the spike protein might give SARS-CoV-2 and its variants an advantage to easily enter the host cells 348 In a region of high prevalence of VOCs, the potential vulnerability of S gene targeted assay can be used as an indirect screening method for the presence of VOCs. A single run of a multi-target isothermal-based assay would be sufficient for the screening method. Targeting the S-gene along with N, E, and ORF1ab genes in the assay and getting negative or reduced sensitivity for the S gene while positive results for other genes can be used in this approach.

However, such screening method for VOCs should be interpreted cautiously and, at times, must be validated using genome sequencing. A more direct approach for VOCs screening would be obtained by a multiplex isothermal-based assay that includes genes such as N,

ORF1ab, E and one or more common mutations in the S protein of different VOCs as targets.

By including common mutations such as D616G and or N501Y in the primer and probe design 352 , S gene-targeted assay can be reconfigured. A DARQ-LAMP-based approach or similar multiple probes-based approach can be used to detect a large number of variants in a single test.

Infectious VOCs might continue to emerge with the course of pandemic and postpandemic. Thus, it is crucial to identify new variants and monitor their mutations by genome sequencing and accordingly reconfigure existing primer and probes of any isothermal-based assay. "LamPORE COVID-19" assay, that combined an isothermal method LAMP, and sequencing, is a good example. With the emergence of SARS-CoV-2 variants, this sequencingbased isothermal technology has immense potential to detect the presence of variants in the sample.

RT-PCR, the current widely employed method for detecting SARS-CoV-2, is inconvenient for routine testing. It suffers from a long sample-to-result time and is performed by expensive equipment, thus being inconvenient for POC diagnosis. As a potential solution, different isothermal methods have been reported and developed. Isothermal-based assays of viral detection show robust performance with high potential at the POC. A significant number of isothermal-based commercial diagnostic kits have been EUA approved displaying their workability with minimal sample processing, and sample to answer diagnosis. Isothermal J o u r n a l P r e -p r o o f assays involving diverse CRISPR/Cas systems show great potential. However, isothermalbased sensitive multiplex assay is still nascent. A great advantage is that different types of isothermal assays with a wide range of temperatures can be performed using an inexpensive and simple heating device. We hope that these isothermal approaches in the post-COVID-19 era will expand into more advanced avenues toward efficient, simple, rapid sample-to-answer pathogen diagnostic tools.

As the main author, MMI planned and conceptualized the project, designed all figures, and searched literatures. MMI wrote the manuscript and addressed reviewers comments. MMI revised and edited the manuscript. DK, occasionally, helped with proof reading.

The proximal origin of SARS-CoV-2

Virus origin / Origins of the SARS-CoV-2 virus

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus-Infected Pneumonia

COVID-19) -World Health Organization

Waning Immunity after the BNT162b2 Vaccine in Israel

Dynamics of antibody response to BNT162b2 vaccine after six months: a longitudinal prospective study

A pneumonia outbreak associated with a new coronavirus of probable bat origin

A new coronavirus associated with human respiratory disease in China

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses

The Architecture of SARS-CoV-2 Transcriptome

SARS-CoV-2 (COVID-19) by the numbers

Electron microscopy of SARS-CoV-2: a challenging task -Authors' reply

Diagnosing COVID-19: The Disease and Tools for Detection

Details -Public Health Image Library(PHIL)

Genome-wide analysis of influenza viral RNA and nucleoprotein association

Antigenic Diversity, and Advancements in the Design of a Human Rhinovirus Vaccine

Zika virus genome biology and molecular pathogenesis

Architecture and secondary structure of an entire HIV-1 RNA genome

Complete Genome Sequence of a New Ebola Virus Strain Isolated during the 2017 Likati Outbreak in the Democratic Republic of the Congo

Genome Composition and Divergence of the Novel Coronavirus (2019-nCoV) Originating in China

Decoding SARS-CoV-2 Transmission and Evolution and Ramifications for COVID-19 Diagnosis, Vaccine, and Medicine

Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation

Activation of the SARS coronavirus spike protein via sequential proteolytic cleavage at two distinct sites

Modes of transmission of virus causing COVID-19: implications for IPC precaution recommendations

Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2

Stability of SARS-CoV-2 in different environmental conditions

Why does COVID-19 disproportionately affect older people?

Efficient high-throughput SARS-CoV-2 testing to detect asymptomatic carriers

Testing at scale during the COVID-19 pandemic

SARS-CoV-2 Vaccines

Diagnostics for SARS-CoV-2 infections

Interpreting Diagnostic Tests for SARS-CoV-2

Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis

Serology testing in the COVID-19 pandemic response

Review of Current Advances in Serologic Testing for COVID-19

Factors Associated With Prolonged Viral RNA Shedding in Patients with Coronavirus Disease 2019 (COVID-19) | Clinical Infectious Diseases | Oxford Academic

Temporal dynamics in viral shedding and transmissibility of COVID-19

The Incubation Period of Coronavirus Disease 2019 (COVID-19) From Publicly Reported Confirmed Cases: Estimation and Application

Incubation period of COVID-19: a rapid systematic review and meta-analysis of observational research

Viral load of SARS-CoV-2 in clinical samples

Virological assessment of hospitalized patients with COVID-2019

SARS-CoV-2, SARS-CoV, and MERS-CoV viral load dynamics, duration of viral shedding, and infectiousness: a systematic review and meta-analysis

Higher viral loads in asymptomatic COVID-19 patients might be the invisible part of the iceberg

SARS-CoV-2 detection, viral load and infectivity over the course of an infection

Extraction: The Past and The Present

RT-qPCR Testing of SARS-CoV-2: A Primer

SARS-CoV-2 transmission without symptoms

COVID-19 diagnostics in context

Two Pandemics, One Challenge-Leveraging Molecular Test Capacity of Tuberculosis Laboratories for Rapid COVID-19 Case-Finding

PCR inhibitors -occurrence, properties and removal -Schrader -2012

Linear nicking endonuclease-mediated strand displacement DNA amplification

Graphene oxide assisted light-up aptamer selection against Thioflavin T for label-free detection of microRNA

Thioflavin T as a noncovalent reporter for a label-free, non-enzymatic, catalytic DNA amplifier

Sensitive and rapid detection of microRNAs using hairpin probes-mediated exponential isothermal amplification

Isothermal reactions for the amplification of oligonucleotides

Label-free thioflavin T/G-quadruplex-based real-time strand displacement amplification for biosensing applications

Ultrasensitive Detection of microRNAs by Exponential Isothermal Amplification

Loop-mediated isothermal amplification of DNA

Accelerated reaction by loop-mediated isothermal amplification using loop primers

Colorimetric Detection of Horse Meat Based on Loop-Mediated Isothermal Amplification (LAMP)

Bioanalytical applications of isothermal nucleic acid amplification techniques

Developing RT-LAMP Assays for Detection of SARS-CoV-2 in Saliva

MorphoCatcher: a multiple-alignment based web tool for target selection and designing taxon-specific primers in the loop-mediated isothermal amplification method

GLAPD: Whole Genome Based LAMP Primer Design for a Set of

Loop-mediated isothermal amplification (LAMP): a rapid, accurate, and cost-effective diagnostic method for infectious diseases

Detection of loop-mediated isothermal amplification reaction by turbidity derived from magnesium pyrophosphate formation

Real-time turbidimetry of LAMP reaction for quantifying template DNA

LAMP real-time turbidity detection for fowl adenovirus

Colorimetric detection of loopmediated isothermal amplification reaction by using hydroxy naphthol blue

A modified visual loop-mediated isothermal amplification method for diagnosis and differentiation of main pathogens from Mycobacterium tuberculosis complex

Loop-mediated isothermal amplification (LAMP) of gene sequences and simple visual detection of products

Visual detection of isothermal nucleic acid amplification using pH-sensitive dyes

Use of Malachite Green-Loop Mediated Isothermal Amplification for Detection of Plasmodium spp

Instrument-Free Point-of-Care Molecular Detection of Zika Virus

Color SARS-CoV-2 RT-LAMP Diagnostic Assay -EUA Summary

Quantification of colorimetric isothermal amplification on the smartphone and its open-source app for point-of-care pathogen detection

Real-time colorimetric LAMP methodology for quantitative nucleic acids detection at the point-of-care

Quantification of Colorimetric Loop-mediated Isothermal Amplification Process

Rapid isothermal amplification and portable detection system for SARS-CoV-2

Development of a Loop-Mediated Isothermal Amplification Assay for Rapid Detection of Subgroup J Avian Leukosis Virus

Rapid molecular diagnostics of COVID-19 by RT-LAMP in a centrifugal polystyrene-toner based microdevice with end-point visual detection

Emerging Loop-Mediated Isothermal Amplification-Based Microchip and Microdevice Technologies for Nucleic Acid Detection

Development and application of loop-mediated isothermal amplification (LAMP) for detection of Plasmopara viticola

Real-Time Reverse Transcription Loop-Mediated Isothermal Amplification for Rapid Detection of West Nile Virus

Development of a loop-mediated isothermal amplification for rapid detection of orf virus

Classification of Multiple DNA Dyes Based on Inhibition Effects on Real-Time Loop-Mediated Isothermal Amplification (LAMP): Prospect for Point of Care Setting

Comparison of fluorescent intercalating dyes for quantitative loop-mediated isothermal amplification (qLAMP)

Comparison of multiple DNA dyes for real-time PCR: effects of dye concentration and sequence composition on DNA amplification and melting temperature

SYTO dyes and EvaGreen outperform SYBR Green in real-time PCR

A real-time microfluidic multiplex electrochemical loop-mediated isothermal amplification chip for differentiating bacteria

Semi-real time electrochemical monitoring for influenza virus RNA by reverse transcription loop-mediated isothermal amplification using a USB powered portable potentiostat

Multiplex Real-Time Loop-Mediated Isothermal Amplification Using an Electrochemical DNA Chip Consisting of a Single Liquid-Flow Channel

A novel voltammetric approach for real-time electrochemical detection of targeted nucleic acid sequences using LAMP

Gold nanoparticle-mediated nucleic acid isothermal amplification with enhanced specificity

Rapid and sensitive detection of human African trypanosomiasis by loop-mediated isothermal amplification combined with a lateral-flow dipstick

Brief review of monitoring methods for loop-mediated isothermal amplification (LAMP)

Tracking the re-emergence of epidemic chikungunya virus in Indonesia

Epidemic resurgence of Chikungunya virus in democratic Republic of the Congo: identification of a new central African strain

Genome microevolution of chikungunya viruses causing the Indian Ocean outbreak

Re-emergence of Chikungunya and O'nyong-nyong viruses: evidence for distinct geographical lineages and distant evolutionary relationships

Rapid and Real-Time Detection of Chikungunya Virus by Reverse Transcription Loop-Mediated Isothermal Amplification Assay

Detection of dengue viruses using reverse transcription-loop-mediated isothermal amplification

Rapid discriminative detection of dengue viruses via loop mediated isothermal amplification

Sensitive and rapid detection of Zika virus by loop-mediated isothermal amplification

Rapid and sensitive detection of Zika virus by reverse transcription loopmediated isothermal amplification

Ebola virus disease epidemic in West Africa: lessons learned and issues arising from West African countries

Molecular Diagnostic Field Test for Point-of-Care Detection of Ebola Virus Directly From Blood

Pandemic (H1N1) 2009 Virus Revisited: an Evolutionary Retrospective

Mobile and accurate detection system for infection by the 2009 pandemic influenza A (H1N1) virus with a pocket-warmer reverse-transcriptase loop-mediated isothermal amplification

Development and Evaluation of a Novel Loop-Mediated Isothermal Amplification Method for Rapid Detection of Severe Acute Respiratory Syndrome Coronavirus

Development of fluorescent reverse transcription loop-mediated isothermal amplification (RT-LAMP) using quenching probes for the detection of the Middle East respiratory syndrome coronavirus

Detection of Middle East respiratory syndrome coronavirus using reverse transcription loop-mediated isothermal amplification (RT-LAMP)

Real-Time Sequence-Validated Loop-Mediated Isothermal Amplification Assays for Detection of Middle East Respiratory Syndrome Coronavirus (MERS-CoV)

Could mutations of SARS-CoV-2 suppress diagnostic detection?

The Impact of Mutations in SARS-CoV-2 Spike on Viral Infectivity and Antigenicity

Nucleic Acid-Based Technologies Targeting Coronaviruses

Development of a reverse transcription-loop-mediated isothermal amplification as a rapid early-detection method for novel SARS-CoV-2

Why are RNA virus mutation rates so damn high?

Laboratory Diagnosis of COVID-19: Current Issues and Challenges

A colorimetric RT-LAMP assay and LAMP-sequencing for detecting SARS-CoV-2 RNA in clinical samples

Comparative evaluation of 19 reverse transcription loop-mediated isothermal amplification assays for detection of SARS-CoV-2

A Novel Reverse Transcription Loop-Mediated Isothermal Amplification Method for Rapid Detection of SARS-CoV-2

Rapid detection of novel coronavirus/Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) by reverse transcription-loop-mediated isothermal amplification

Rapid Detection of COVID-19 Coronavirus Using a Reverse Transcriptional Loop-Mediated Isothermal Amplification (RT-LAMP) Diagnostic Platform

Diagnostic potential of multitargeted LAMP (loop-mediated isothermal amplification) for osteoarticular tuberculosis

Multiplexing primer/probe sets for detection of SARS-CoV-2 by qRT-PCR

Rapid and visual detection of 2019 novel coronavirus (SARS-CoV-2) by a reverse transcription loop-mediated isothermal amplification assay

Development and Validation of a Rapid, Single-Step Reverse Transcriptase Loop-Mediated Isothermal Amplification (RT-LAMP) System Potentially to Be Used for Reliable and High-Throughput Screening of COVID-19

RT-LAMP for rapid diagnosis of coronavirus SARS-CoV-2

Multiplex reverse transcription loop-mediated isothermal amplification combined with nanoparticle-based lateral flow biosensor for the diagnosis of COVID-19

Technical aspects of nicking enzyme assisted amplification

Prospective evaluation of three rapid molecular tests for seasonal influenza in patients presenting at an emergency unit

Natural and engineered nicking endonucleases-from cleavage mechanism to engineering of strand-specificity

Nicking endonucleases

Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges

Nucleic acid sequence-based amplification

Real-Time Nucleic Acid Sequence-Based Amplification Assay for Detection of Hepatitis A Virus

Design and evaluation of a human immunodeficiency virus type 1 RNA assay using nucleic acid sequence-based amplification technology able to quantify both group M and O viruses by using the long terminal repeat as target

Characterization of the quantitative HCV NASBA assay

Isothermal Amplification of Nucleic Acids

INSIGHT: A population-scale COVID-19 testing strategy combining point-of-care diagnosis with centralized high-throughput sequencing

Isothermal amplified detection of DNA and RNA

Quantitative Detection of Aspergillus spp. by Real-Time Nucleic Acid Sequence-Based Amplification

Real-time molecular beacon NASBA for rapid and sensitive detection of norovirus GII in clinical samples

Simple, low-cost fabrication of acrylic based droplet microfluidics and its use to generate DNA-coated particles

Integrated microfluidic tmRNA purification and real-time NASBA device for molecular diagnostics

Real-Time Nucleic Acid Sequence-Based Amplification in Nanoliter Volumes

Parallel nanoliter detection of cancer markers using polymer microchips

Nucleic Acid Sequence-Based Amplification (nasba) in Molecular Bacteriology: A Procedural Guide

Nucleic Acid Sequence-Based Amplification Assay for Human Papillomavirus mRNA Detection and Typing: Evidence for DNA Amplification

Sensitive Commercial NASBA Assay for the Detection of Respiratory Syncytial Virus in Clinical Specimen

Transcription-mediated amplification and hybridisation protection assay to determine BCR-ABL transcript levels in patients with chronic myeloid leukaemia

Detection of residual hepatitis C virus RNA by transcription-mediated amplification in patients with complete virologic response according to polymerase chain reaction-based assays

Comparison of transcription mediated amplification (TMA) and reverse transcription polymerase chain reaction (RT-PCR) for detection of hepatitis C virus RNA in liver tissue

Review: a comprehensive summary of a decade development of the recombinase polymerase amplification

Equipment-Free Incubation of Recombinase Polymerase Amplification Reactions Using Body Heat

Rapid Detection of SARS-CoV-2 by Low Volume Real-Time Single Tube Reverse Transcription Recombinase Polymerase Amplification Using an Exo Probe with an Internally Linked Quencher (Exo-IQ)

Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA

Suitcase Lab for Rapid Detection of SARS-CoV-2 Based on Recombinase Polymerase Amplification Assay

PrimedRPA: primer design for recombinase polymerase amplification assays

Single-strand RPA for rapid and sensitive detection of SARS-CoV-2 RNA. medRxiv (2020)

Two-Stage Isothermal Enzymatic Amplification for Concurrent Multiplex Molecular Detection

A Single and Two-Stage, Closed-Tube, Molecular Test for the 2019 Novel Coronavirus (COVID-19) at Home, Clinic, and Points of Entry

Rolling Circle Amplification: Applications in Nanotechnology and Biodetection with Functional Nucleic Acids

Rolling circle amplification: a versatile tool for chemical biology, materials science and medicine

Digital Rolling Circle Amplification-Based Detection of Ebola and Other Tropical Viruses

Real-time detection of H5N1 influenza virus through hyperbranched rolling circle amplification

Rapid and Sensitive Detection of Severe Acute Respiratory Syndrome Coronavirus by Rolling Circle Amplification

Homogeneous circle-to-circle amplification for real-time optomagnetic detection of SARS-CoV-2 RdRp coding sequence

Rapid electrochemical detection of coronavirus SARS-CoV-2

Specific detection of DNA and RNA targets using a novel isothermal nucleic acid amplification assay based on the formation of a three-way junction structure

Detection of virus mRNA within infected host cells using an isothermal nucleic acid amplification assay: marine cyanophage gene expression within Synechococcus sp

Isothermal SARS-CoV-2 Diagnostics: Tools for Enabling Distributed Pandemic Testing as a Means of Supporting Safe Reopenings

Helicase dependent OnChipamplification and its use in multiplex pathogen detection

Attomolar quantitation of Mycobacterium tuberculosis by asymmetric helicase-dependent isothermal DNA-amplification and electrochemical detection

Helicase-dependent isothermal DNA amplification

Helicase Dependent Amplification | Point of Care Testing from Quidel

Nucleic acid assay system for tier II laboratories and moderately complex clinics to detect HIV in low-resource settings

Multiple strategies to improve sensitivity, speed and robustness of isothermal nucleic acid amplification for rapid pathogen detection

Evaluation of Chlamydia trachomatis and Neisseria gonorrhoeae detection in urine, endocervical, and vaginal specimens by a multiplexed isothermal thermophilic helicase-dependent amplification (tHDA) assay

Detection and species identification of malaria parasites by isothermal tHDA amplification directly from human blood without sample preparation

Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile

Low cost extraction and isothermal amplification of DNA for infectious diarrhea diagnosis

Sensitive Quantification of MicroRNAs by Isothermal Helicase-Dependent Amplification

Helicase-dependent isothermal amplification: a novel tool in the development of molecular-based analytical systems for rapid pathogen detection

Zero-Background Helicase-Dependent Amplification and Its Application to Reliable Assay of Telomerase Activity in Cancer Cell by Eliminating Primer-Dimer Artifacts

Cross-Priming Amplification for Rapid Detection of Mycobacterium tuberculosis in Sputum Specimens

Cross Priming Amplification: Mechanism and Optimization for Isothermal DNA Amplification

Cross-priming amplification-based lateral flow strip as a novel tool for rapid on-site detection of wild-type pseudorabies virus

Detection of Severe Fever with Thrombocytopenia Syndrome Virus by Reverse Transcription-Cross-Priming Amplification Coupled with Vertical Flow Visualization

Establishment and application of cross-priming isothermal amplification coupled with lateral flow dipstick (CPA-LFD) for rapid and specific detection of red-spotted grouper nervous necrosis virus

Reverse Transcription Cross-Priming Amplification-Nucleic Acid Test Strip for Rapid Detection of Porcine Epidemic Diarrhea Virus

Rapid Detection of Prunus Necrotic Ringspot Virus by Reverse Transcription-cross-priming Amplification Coupled with Nucleic Acid Test Strip Cassette

Pioneers of revolutionary CRISPR gene editing win chemistry Nobel

CRISPR-Cas systems: Prokaryotes upgrade to adaptive immunity

The size of the immune repertoire of bacteria

crRNA and tracrRNA guide Cas9-mediated DNA interference in Streptococcus thermophilus

CRISPR-Cas: Converting A Bacterial Defence Mechanism into A State-of-the-Art Genetic Manipulation Tool

CRISPR-Cas adaptation: insights into the mechanism of action

Single-stranded DNA cleavage by divergent CRISPR-Cas9 enzymes

CRISPR Provides Acquired Resistance Against Viruses in Prokaryotes

Multiplex Genome Engineering Using CRISPR/Cas Systems

Targeted genome engineering in human cells with the Cas9 RNA-guided endonuclease

RNA-Guided Human Genome Engineering via Cas9

A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity

Functional DNA Regulated CRISPR-Cas12a Sensors for Point-of-Care Diagnostics of Non-Nucleic-Acid Targets

Rapid and sensitive exosome detection with CRISPR/Cas12a

Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects

Strategies for the CRISPR-Based Therapeutics

Nucleic acid detection with CRISPR-Cas13a/C2c2

Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies

CRISPR/cas systems redefine nucleic acid detection: Principles and methods

Integrating CRISPR-Cas12a with a DNA circuit as a generic sensing platform for amplified detection of microRNA

A CRISPR-Cas9-triggered strand displacement amplification method for ultrasensitive DNA detection

Clustered Regularly Interspaced Short Palindromic Repeats/Cas9 Triggered Isothermal Amplification for Site-Specific Nucleic Acid Detection

HOLMESv2: A CRISPR-Cas12b-Assisted Platform for Nucleic Acid Detection and DNA Methylation Quantitation

Annotation and Classification of CRISPR-Cas Systems

Programmed DNA destruction by miniature CRISPR-Cas14 enzymes

CRISPR-Cas9 Structures and Mechanisms

Review of CRISPR/Cas9 sgRNA Design Tools

CHOPCHOP: a CRISPR/Cas9 and TALEN web tool for genome editing

A quick guide to CRISPR sgRNA design tools

CRISPR-Local: a local single-guide RNA (sgRNA) design tool for non-reference plant genomes

Protospacer Adjacent Motif-Induced Allostery Activates CRISPR-Cas9

Short motif sequences determine the targets of the prokaryotic CRISPR defence system

Structural and Mechanistic Basis of PAM-Dependent Spacer Acquisition in CRISPR-Cas Systems

PAM identification by CRISPR-Cas effector complexes: diversified mechanisms and structures

CRISPR technologies and the search for the PAM-free nuclease

Discovery and Functional Characterization of Diverse Class 2 CRISPR-Cas Systems

Chemistry of Class 1 CRISPR-Cas effectors: Binding, editing, and regulation

Diverse Class 2 CRISPR-Cas Effector Proteins for Genome Engineering Applications

CRISPR technology incorporating amplification strategies: molecular assays for nucleic acids, proteins, and small molecules

Crystal Structure of Cas9 in Complex with Guide RNA and Target DNA

Cas9-crRNA ribonucleoprotein complex mediates specific DNA cleavage for adaptive immunity in bacteria

CRISPR/Cas9 in Genome Editing and Beyond

Double Nicking by RNA-Guided CRISPR Cas9 for Enhanced Genome Editing Specificity

Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression

Catalytically inactive Cas9 impairs DNA replication fork progression to induce focal genomic instability

In trans paired nicking triggers seamless genome editing without doublestranded DNA cutting

A robust CRISPR-Cas9-based fluorescent reporter assay for the detection and quantification of DNA double-strand break repair

Colorimetric Detection of SARS-CoV-2 and Drug-Resistant pH1N1 Using CRISPR/dCas9

An RNA-Guided Cas9 Nickase-Based Method for Universal Isothermal DNA Amplification

The next generation of CRISPR-Cas technologies and applications

CRISPR Systems for COVID-19 Diagnosis

Multiplexed CRISPR technologies for gene editing and transcriptional regulation

A short overview of CRISPR-Cas technology and its application in viral disease control

CRISPR-Cas12a target binding unleashes indiscriminate single-stranded DNase activity

Detect and destroy: CRISPR-based technologies for the response against viruses

CRISPR-Cas14 is now part of the artillery for gene editing and molecular diagnostic

PAM recognition by miniature CRISPR-Cas12f nucleases triggers programmable double-stranded DNA target cleavage

Programmable Inhibition and Detection of RNA Viruses Using Cas13

The Molecular Architecture for RNA-Guided RNA Cleavage by Cas13a

Amplification-free detection of SARS-CoV-2 with CRISPR-Cas13a and mobile phone microscopy

Field-deployable viral diagnostics using CRISPR-Cas13

Ultrasensitive and visual detection of SARS-CoV-2 using all-in-one dual CRISPR-Cas12a assay

Ultra-sensitive and high-throughput CRISPR-p owered COVID-19 diagnosis

Cas12aVDet: A CRISPR/Cas12a-Based Platform for Rapid and Visual Nucleic Acid Detection

Ultrasensitive CRISPR-based diagnostic for field-applicable detection of Plasmodium species in symptomatic and asymptomatic malaria

A rapid and sensitive CRISPR/Cas12a based lateral flow biosensor for the detection of Epstein-Barr virus

SHERLOCK: nucleic acid detection with CRISPR nucleases

Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities

Multiplexed and portable nucleic acid detection platform with Cas13, Cas12a, and Csm6

CRISPR-Cas12-based detection of SARS-CoV-2

CRISPR/Cas Systems towards Next-Generation Biosensing

Enhancement of trans-cleavage activity of Cas12a with engineered crRNA enables amplified nucleic acid detection

A more efficient CRISPR-Cas12a variant derived from Lachnospiraceae bacterium MA2020

Development and application of sensitive, specific, and rapid CRISPR-Cas13-based diagnosis

Point-of-care testing for COVID-19 using SHERLOCK diagnostics. medRxiv (2020)

iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2

Sequence-specific detection method for reverse transcription, loop-mediated isothermal amplification of HIV-1

CUT-LAMP: Contamination-Free Loop-Mediated Isothermal Amplification Based on the CRISPR/Cas9 Cleavage

opvCRISPR: One-pot visual RT-LAMP-CRISPR platform for SARS-cov-2 detection

Isothermal Amplification of Nucleic Acids

Microfluidic lab-on-a-foil for nucleic acid analysis based on isothermal recombinase polymerase amplification (RPA)

Development and evaluation of a rapid CRISPR-based diagnostic for COVID-19

Clinical validation of a Cas13-based assay for the detection of SARS-CoV-2 RNA

Rolling Circular Amplification (RCA)-Assisted CRISPR/Cas9 Cleavage (RACE) for Highly Specific Detection of Multiple Extracellular Vesicle MicroRNAs

CRISPR-Cas12a based internal negative control for nonspecific products of exponential rolling circle amplification

Low-Cost Detection of Zika Virus Using Programmable Biomolecular Components

Design and Validation of Transcription-Mediated-Amplification Nucleic Acid Amplification Tests for Mycoplasma genitalium

CRISPR-Cas12a-assisted nucleic acid detection

CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics

Identification of human metapneumovirus genotypes A and B from clinical specimens by reverse transcription loop-mediated isothermal amplification

Detection Kit | Molecular Test

COVID-19 Rapid Detection Kit

Detectachem MobileDetect-BIO BCC19 test kit for SARS-CoV-2 detection

Emergency use authorization (EUA) summary for Mammoth Biosciences SARS-CoV-2 RNA DETECTR assay

Emergnecy use authorization (EUA) summary for Sherlock Biosciences CRISPR SARS-CoV-2 kit

Aptima® SARS-CoV-2 Assay (Panther® System)

Fully automated detection and differentiation of pandemic and endemic coronaviruses (NL63, 229E, HKU1, OC43 and SARS-CoV-2) on the Hologic Panther Fusion

High-Throughput Transcription-mediated amplification on the Hologic Panther is a highly sensitive method of detection for SARS-CoV-2

Comparison of the ID Now Influenza A & B 2, Cobas Influenza A/B, and Xpert Xpress Flu Point-of-Care Nucleic Acid Amplification Tests for Influenza A/B Virus Detection in Children

Evaluation of Alere i Influenza A&B for rapid detection of influenza viruses A and B

Profile of the Alere i Influenza A & B assay: a pioneering molecular point-of-care test

COVID-19 test

Emergnecy use authorization (EUA) Lucira COVID-19 All-in-one test kit

Real-time COVID-19 testing | Cue

Development of Reverse Transcription Loop-Mediated Isothermal Amplification Assays Targeting Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

A Rapid, Simple, Inexpensive, and Mobile Colorimetric Assay COVID-19-LAMP for Mass On-Site Screening of COVID-19

Integrated sample inactivation, amplification, and Cas13-based detection of SARS-CoV-2. bioRxiv

Methods for viral RNA isolation and PCR amplification for sequencing of near full-length HIV-1 genomes

Extraction-free SARS-CoV-2 detection by rapid RT-qPCR universal for all primary respiratory materials

Rapid Direct Nucleic Acid Amplification Test without RNA Extraction for SARS-CoV-2 Using a Portable PCR Thermocycler

DIRECT RT-qPCR DETECTION OF SARS-CoV-2 RNA FROM PATIENT NASOPHARYNGEAL SWABS WITHOUT AN RNA EXTRACTION

Massive and rapid COVID-19 testing is feasible by extraction-free SARS-CoV-2 RT

Simple and Highly Sensitive Molecular Diagnosis of Zika Virus by Lateral Flow Assays

SARS-CoV-2 detection using isothermal amplification and a rapid, inexpensive protocol for sample inactivation and purification

Clinical Assessment and Validation of a Rapid and Sensitive SARS-CoV-2

Test Using Reverse Transcription Loop-Mediated Isothermal Amplification Without the Need for RNA Extraction

Direct on-the-spot detection of SARS-CoV-2 in patients

Saliva or Nasopharyngeal Swab Specimens for Detection of SARS-CoV-2

SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity

The human salivary microbiome exhibits temporal stability in bacterial diversity

Saliva TwoStep for rapid detection of asymptomatic SARS-CoV-2 carriers

Simpler, Faster, and Sensitive Zika Virus Assay Using Smartphone Detection of Loop-mediated Isothermal Amplification on Paper Microfluidic Chips

Rapid Detection of Influenza Virus Subtypes Based on an Integrated Centrifugal Disc

Point-of-Care Devices to Detect Zika and Other Emerging Viruses

Progress in loop-mediated isothermal amplification assay for detection of Schistosoma mansoni DNA: towards a ready-to-use test

The epidemiology and clinical characteristics of co-infection of SARS-CoV-2 and influenza viruses in patients during COVID-19 outbreak

A single-tube multiplex PCR for rapid detection in feces of 10 viruses causing diarrhea

PCR: Optimization and Application in Diagnostic Virology

A novel RT-multiplex PCR for detection of Aichi virus, human parechovirus, enteroviruses, and human bocavirus among infants and children with acute gastroenteritis

Multiplex nested RT-PCR for detecting avian influenza virus, infectious bronchitis virus and Newcastle disease virus

A novel multiplex PCR for virus detection by melting curve analysis

Information for Laboratories about Coronavirus (COVID-19)

CRISPR/Cas Powered Multiplexed Biosensing

Simultaneous multiple target detection in real-time loop-mediated isothermal amplification

Development of multiplexed reverse-transcription loop-mediated isothermal amplification for detection of SARS-CoV-2 and influenza viral RNA

Quenching of Unincorporated Amplification Signal Reporters in Reverse-Transcription Loop-Mediated Isothermal Amplification Enabling Bright, Single-Step, Closed-Tube, and Multiplexed Detection of RNA Viruses

Molecular Beacons: Probes that Fluoresce upon Hybridization

Detection of SARS-CoV-2 RNA using RT-LAMP and molecular beacons

CRISPR-Cas12a Coupled with Platinum Nanoreporter for Visual Quantification of SNVs on a Volumetric Bar-Chart Chip

Sample Pooling as a Strategy to Detect Community Transmission of SARS-CoV-2

Lessons from applied large-scale pooling of 133,816 SARS-CoV-2 RT-PCR tests

Emerging SARS-CoV-2 variants reduce neutralization sensitivity to convalescent sera and monoclonal antibodies

Tracking SARS-CoV-2 variants

Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants

Structure, Function, and Evolution of Coronavirus Spike Proteins

SARS-CoV-2 variants, spike mutations and immune escape

Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization

The role of furin cleavage site in SARS-CoV-2 spike protein-mediated membrane fusion in the presence or absence of trypsin

How Dangerous Is the Delta Variant (B.1.617.2)? ASM

SARS-CoV-2 Viral Mutations: Impact on COVID-19 Tests

Reliability of Spike Gene Target Failure for ascertaining SARS-CoV-2 lineage B.1.1.7 prevalence in a hospital setting

A Rapid SARS-CoV-2 Variant Detection by Molecular-Clamping Based RT-qPCR

All figures were created with BioRender.com. Figure 1